APA (7th ed.) Citation

Giannicola, R., D'Arrigo, G., Botta, C., Agostino, R., Del Medico, P., Falzea, A. C., . . . Correale, P. (2019). Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab. Molecular & Clinical Oncology, 11(1), 81. https://doi.org/10.3892/mco.2019.1859

Chicago Style (17th ed.) Citation

Giannicola, Rocco, et al. "Early Blood Rise in Auto-antibodies to Nuclear and Smooth Muscle Antigens Is Predictive of Prolonged Survival and Autoimmunity in Metastatic-non-small Cell Lung Cancer Patients Treated with PD-1 Immune-check Point Blockade by Nivolumab." Molecular & Clinical Oncology 11, no. 1 (2019): 81. https://doi.org/10.3892/mco.2019.1859.

MLA (9th ed.) Citation

Giannicola, Rocco, et al. "Early Blood Rise in Auto-antibodies to Nuclear and Smooth Muscle Antigens Is Predictive of Prolonged Survival and Autoimmunity in Metastatic-non-small Cell Lung Cancer Patients Treated with PD-1 Immune-check Point Blockade by Nivolumab." Molecular & Clinical Oncology, vol. 11, no. 1, 2019, p. 81, https://doi.org/10.3892/mco.2019.1859.